Alex Escalona
Overview
Explore the profile of Alex Escalona including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
702
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Oyola C, Berry M, Salazar M, De Abreu D, Formiga A, Escalona A, et al.
Obes Surg
. 2024 Aug;
34(10):3762-3770.
PMID: 39198380
Purpose: Medical devices benefit patients living with overweight or obesity, but studies in the adolescent population are lacking. The goal of this study was to collect information on the performance...
2.
Sapunar J, Escalona A, Araya A, Aylwin C, Bastias M, Boza C, et al.
Rev Med Chil
. 2019 Feb;
146(10):1175-1183.
PMID: 30724982
Diabetes Mellitus (DM) and obesity are a public health problem in Chile. Bariatric surgery is the most effective treatment alternative to achieve a significant and sustained weight reduction in patients...
3.
Quezada N, Munoz R, Morelli C, Turiel D, Hernandez J, Pimentel F, et al.
Surg Endosc
. 2017 Jul;
32(1):260-267.
PMID: 28664427
Background: The duodenal-jejunal bypass liner (DJBL) is an endoscopic device that mimics the duodenal-jejunal exclusion component of the Roux-en-Y gastric bypass. Previous studies assessing the efficacy of the DJBL have...
4.
Medina D, Pedreros J, Turiel D, Quezada N, Pimentel F, Escalona A, et al.
PeerJ
. 2017 Jun;
5:e3443.
PMID: 28649469
Bariatric surgery is highly successful in improving health compared to conventional dietary treatments. It has been suggested that the gut microbiota is a relevant factor in weight loss after bariatric...
5.
Escalona A, Munoz R, Irribarra V, Solari S, Allende F, Miquel J
Surg Obes Relat Dis
. 2016 Mar;
12(4):763-769.
PMID: 26948941
Background: Bariatric surgery is the most effective treatment alternative in morbid obesity. The mechanisms contributing to these benefits remain poorly understood. Bile acids (BAs) are mediators of different regulatory functions...
6.
Norero E, Baez S, Briceno E, Martinez C, Ceroni M, Escalona A, et al.
Rev Med Chil
. 2015 May;
143(3):281-8.
PMID: 26005813
Background: The laparoscopic approach for the treatment of gastric tumors has many advantages. Aim: To evaluate the results of a laparoscopic gastrectomy program developed in a public hospital. Patients And...
7.
Quezada N, Leon F, Jones A, Varas J, Funke R, Crovari F, et al.
Obes Surg
. 2015 Feb;
25(4):615-21.
PMID: 25638655
Background: Internal hernias (IH) after Roux-en-Y gastric bypass (RYGB) are a serious concern among surgeons and are often under-diagnosed due to heterogeneity of clinical manifestations. Our aim is to assess...
8.
Munoz R, Escalona A
Curr Cardiol Rep
. 2014 Feb;
16(3):454.
PMID: 24570355
Endoscopic placement of the duodenal-jejunal bypass liner (DJBL) in morbidly obese patients induces significant weight loss. Additionally, early studies reported significant improvements in several parameters of glucose homeostasis in morbidly...
9.
Munoz R, Dominguez A, Munoz F, Munoz C, Slako M, Turiel D, et al.
Surg Endosc
. 2013 Nov;
28(4):1056-62.
PMID: 24196558
Introduction: Endoscopic treatment with the duodenal-jejunal bypass liner (DJBL) leads to significant weight loss in obese patients. We sought to identify clinical factors associated with weight loss in obese patients...
10.
Guzman S, Manrique M, Raddatz A, Norero E, Salinas J, Achurra P, et al.
Rev Med Chil
. 2013 Oct;
141(5):553-61.
PMID: 24089268
Background: Bariatric surgery is the gold-standard treatment for morbid obesity because it has low morbidity rates in high-volume centers and generates long term sustained weight loss. Aim: To describe our...